IDiyas

For the Inventor, By the Inventor

Emeryville, CA, United States of America

Annette Olga Walter

USPTO Granted Patents = 12

 

Average Co-Inventor Count = 8.5

ph-index = 3

Forward Citations = 54(Granted Patents)


Location History:

  • Emeryville, CA (US) (2012)
  • Mill Valley, CA (US) (2008 - 2014)

Company Filing History:

goldMedal7 out of 245 
 
Novartis Vaccines & Diagnostics, Gmbh
 patents
silverMedal5 out of 3,923 
 
Novartis Ag
 patents

Years Active: 2008-2014

Loading Chart...
Loading Chart...
12 patents (USPTO):
1. 8822497 - PIM kinase inhibitors and methods of their use (2014-09-02),
2. 8735599 - Substituted imidazole derivates (2014-05-27),
3. 8664256 - Kinesin inhibitors as cancer therapeutics (2014-03-04),
4. 8318791 - Substituted imidazole derivatives (2012-11-27),
5. 8252832 - Kinesin inhibitors as cancer therapeutics (2012-08-28),
6. 8129358 - Substituted pyrazole and triazole compounds as KSP inhibitors (2012-03-06),
7. 8008335 - Indole and benzimidazole derivatives (2011-08-30),
8. 7902240 - Substituted pyrazole and triazole compounds as KSP inhibitors (2011-03-08),
9. 7626040 - Substituted imidazole compounds as KSP inhibitors (2009-12-01),
10. 7608723 - Indole and benzimidazole derivatives (2009-10-27),
11. 7576221 - Substituted imidazole derivatives (2009-08-18),
12. 7470701 - Substituted 2,5-heterocyclic derivatives (2008-12-30),

Sure, I can help you with that. Here is the article about inventor Annette Olga Walter:

Title: Innovator Spotlight: Annette Olga Walter - Pioneering Advancements in Cancer Treatment

Introduction:

Annette Olga Walter, a visionary inventor based in Emeryville, CA, has made significant contributions to the field of biomedical research with a focus on developing novel therapies for cancer treatment. With an impressive portfolio of 12 patents to her name, Walter's innovative work has garnered recognition in the scientific community.

Latest Patents:

1. PIM kinase inhibitors and methods of their use - Walter's groundbreaking patent introduces new compounds and compositions designed to inhibit kinase activity associated with tumorigenesis in human or animal subjects. These innovative inhibitors hold promise for treating various kinase-mediated disorders, particularly cancer.

2. Substituted imidazole derivatives - Walter's latest invention features new substituted imidazole compounds and their pharmaceutical applications. These compounds, along with their formulations, present exciting possibilities for therapeutic interventions in various medical conditions.

Career Highlights:

Having worked with renowned companies like Novartis Vaccines & Diagnostics and Novartis Ag, Walter has gained extensive experience in the pharmaceutical industry. Her career highlights include spearheading research projects aimed at enhancing the efficacy of cancer treatments through targeted kinase inhibition.

Collaborations:

Throughout her career, Annette Olga Walter has collaborated with esteemed colleagues in the field of biomedical research. Notable coworkers such as Paul Andrew Barsanti and Paul A. Renhowe have contributed to the successful development and implementation of her pioneering inventions.

Conclusion:

Annette Olga Walter's ingenuity and dedication to advancing cancer therapeutics exemplify the spirit of innovation in the medical sciences. Her remarkable patents stand as a testament to her vision and expertise, paving the way for transformative breakthroughs in the treatment of kinase-related disorders. Embodying excellence in scientific research, Walter continues to inspire future generations of inventors and researchers in the pursuit of groundbreaking discoveries.

If you need more information or have any other requests regarding innovations, inventions, inventors, patent attorneys, assignees, or patents, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…